| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Sales > Are You a Victim of the Financial Services Industry? |
|
Useful Advices - Are You a Victim of the Financial Services Industry?
Most buyers want to do business with people they can trust: Being trustworthy is key to successful selling. Yet, most salespeople who work in the field of According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product Financial Services have been deliberately and calculatedly misled by their employer- usually a Brokerage Company or an Insurance Company. Is it any wonde ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in r that only 3 out of 20 people who enter the field survive? You are a victim of the financial services industry, if you've been told that: * Plenty of p lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. eople are making a lot of money in the business. Truth: About 15% are making a decent living selling financial services, the rest are struggling. * Most here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe people really need your products and services. Truth: Most people may need your products or services, but most don't want to buy them. Unfortunately, in d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro surance companies don't teach you how to find the High Probability Prospects that do want to buy insurance now. Rather, they want most of their agents to ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc beat the bushes for the low probability prospects - because they work on commission. * You have to really want to help people in order to be successful. easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi Truth: Most people don't want your help. * You need to become very knowledgeable about the technical aspects of financial services. Truth: It *is* helpf nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ul to understand financial services products. It is much more important, however, to become skilled at Prospecting (a form of Marketing) and Selling. * I and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ t's easier to learn how to sell than to learn financial planning. Truth: The reverse is true. It's easy to find highly competent financial planners who w ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ill work on your cases very inexpensively - because they don't know how to sell. Salespeople new to the Financial Services industry are usually victimize ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a d by some, or all, of these Myths. The result? They work hard, they work diligently - and they sell very little. The neophyte salesperson is blamed for no dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod t being persuasive enough, being too thin-skinned, being overly sensitive, or just being lazy. How do the top salespeople in the Insurance and Brokerage cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin industries survive? How do they succeed in earning six and seven-figure incomes, against the odds? The sales stars that we've studied know how to: * Defi tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen e target markets - those willing, and able, to buy from you * Develop a viable prospecting list: A true prospect must meet defined criteria * Maintain c t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ontact with prospects - without annoying them * When to make appointments - and to avoid wasting time with 'low probability' prospects * Make the 'numbe ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust rs game' work to your advantage * How to dramatically boost the probability of successfully closing a sale When you stop being victimized by the Sales M y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products yths perpetuated by your industry, and stop victimizing prospects by perpetuating those myths, you will enjoy real sales success. When you differentiate y . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ourself from your competition, know how to open and maintain real dialogue with prospects, know how to develop mutual trust and respect, and focus your se elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip lling efforts only on viable (High Probability) prospects, you can enjoy considerable success. You don't have to work harder; you have to more competently tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Public Relations & Advertising: A Perfect Marriage How Companies Can Effectively Manage Storm Water Pollution
|